Higher threshold for admission — falls risk and social circumstances
Occupational therapy assessment before discharge
Home safety evaluation for grab bars and trip hazards
Vestibular rehabilitation tolerated and beneficial even in elderly
Pediatrics
Epidemiology in children
Labyrinthitis is uncommon in children — bacterial meningitis is the most common cause of bilateral sensorineural hearing loss in pediatric age group
Meningogenic labyrinthitis after H. influenzae type B meningitis — rare since vaccination
Viral labyrinthitis occurs in school-age children after URI
Presentation differences
Young children may not report vertigo — presents as irritability, vomiting, ataxia, refusal to walk
Hearing loss may be discovered only on audiometry post-illness
HINTS exam reliability limited in young children unable to cooperate
Medication dosing in pediatrics
Ondansetron 0.15 mg/kg IV per dose (maximum 4 mg) every 6–8 hours
Dimenhydrinate 1–1.5 mg/kg PO or IV per dose every 6–8 hours (maximum 25 mg per dose under 6 years; 50 mg per dose 6–12 years)
Meclizine — not recommended under 12 years
Corticosteroids — dexamethasone 0.15 mg/kg/day for meningogenic labyrinthitis to reduce hearing loss
Hearing loss implications in children
Permanent sensorineural hearing loss has major developmental implications — speech, language, education
Urgent audiology referral within days of diagnosis
Cochlear implant candidacy assessment if profound bilateral hearing loss
Labyrinthitis ossificans after bacterial meningitis can impair cochlear implant feasibility — early MRI
Background
Epidemiology
Incidence and prevalence
Labyrinthitis accounts for a minority of AVS presentations — vestibular neuritis is more common
Viral labyrinthitis most common form — peaks in spring and early summer consistent with viral URI seasonality
Peak age of incidence 30–60 years
Slight female predominance in viral labyrinthitis
Bacterial meningitis leading cause of meningogenic labyrinthitis — now rare with H. influenzae B vaccination
Morbidity and outcomes
Vertigo typically resolves over days to weeks with central compensation
Hearing loss may be permanent — varies by severity and etiology
Bacterial labyrinthitis carries higher rate of permanent profound sensorineural hearing loss
Risk of secondary BPPV as sequela — free-floating otoconia from damaged utricle
Up to 30% of patients report persistent chronic imbalance
Pathophysiology
Viral labyrinthitis mechanism
Inflammatory invasion of membranous labyrinth — cochlea and vestibular apparatus simultaneously affected
Most common viruses: HSV-1, VZV, CMV, mumps, influenza, COVID-19
Zhao 2023: HSV-1 induces inflammatory cascade in spiral ganglion neurons and vestibular cells
Neuronal degeneration leads to permanent hearing loss and incomplete vestibular recovery
HHV-6 and HHV-7 reactivation implicated — El-Hussein 2020 case series
Bacterial labyrinthitis mechanisms
Otogenic: direct spread from middle ear via round window membrane or bony erosion from cholesteatoma
Meningogenic: retrograde spread from subarachnoid space via cochlear aqueduct — most common route
Pathology: suppurative inflammation, endolymph and perilymph invasion, labyrinthitis ossificans as sequela
Wiedermann 1986: H. influenzae meningitis model — perilymphatic infection precedes ossification
Vestibular compensation
Central vestibular compensation mediated by cerebellum and brainstem
Static symptoms (spontaneous nystagmus, skew) resolve first — days to weeks
Dynamic symptoms (head-motion instability) require weeks to months
Prolonged vestibular suppressant use impairs cerebellar compensation — limits recovery
Therapeutic Considerations
Rationale for limiting vestibular suppressants
Central compensation requires asymmetric vestibular input to drive cerebellar adaptation
Meclizine and benzodiazepines reduce asymmetric input — delay compensation
GRACE-3 and evidence-based guidelines recommend maximum 3–5 days of suppressants
Corticosteroid evidence base
Fishman Cochrane 2011: corticosteroids for vestibular neuritis — modest improvement in short-term vestibular function but insufficient data for long-term hearing or vestibular outcomes
Evidence extrapolated to labyrinthitis — no dedicated RCT for labyrinthitis specifically
Benefit may relate to reduction of cochlear inflammatory edema
Vestibular rehabilitation evidence
Systematic review data support vestibular rehabilitation as most effective long-term intervention
Early initiation associated with faster recovery and better long-term outcomes
Home exercise programs effective when supervised PT not immediately available
Hearing loss intervention timing
Early corticosteroid use may reduce severity of hearing loss — time-sensitive
Intratympanic dexamethasone — ENT-administered salvage therapy for profound unilateral hearing loss
Cochlear implant candidacy for bilateral profound loss
Patient Discharge Instructions
copy discharge instructions
Diagnosis and expected course
You have been diagnosed with labyrinthitis — an inflammation of the inner ear causing dizziness and hearing changes
Dizziness and spinning sensation typically improves significantly over the first 3–7 days
Mild imbalance may persist for several weeks to months
Hearing loss, if present, may be permanent — follow-up with a hearing specialist is essential
Medications prescribed
Take your prescribed anti-nausea medication only as needed for severe symptoms
Stop vestibular suppressant medications after 3–5 days even if mild dizziness persists — stopping these medications helps your brain adapt and speeds your recovery
Do not take meclizine or dimenhydrinate for longer than 5 days without medical advice
Take any prescribed steroid exactly as directed and do not stop early without consulting your doctor
Activity restrictions
Do not drive until dizziness has completely resolved
Do not operate heavy machinery or work at heights
Move slowly when changing positions to reduce fall risk
Use handrails on stairs and remove loose rugs or trip hazards at home
Have someone with you for the first 24–48 hours
Follow-up appointments
Ear, nose, and throat specialist or audiologist within 1–2 weeks for a hearing test
Family doctor within 1 week for symptom reassessment
Vestibular physiotherapy referral — exercises to help your brain compensate for inner ear damage
Return to emergency department immediately if
New slurred speech, facial drooping, arm or leg weakness or numbness
Sudden severe headache unlike any before
Double vision or sudden vision changes
Dizziness suddenly worsens after initial improvement
High fever, severe ear pain, or neck stiffness
Unable to keep fluids down after taking anti-nausea medication
New difficulty walking or balance worse than on discharge
References
Guidelines and key sources
GRACE-3 — Edlow JA et al. Guidelines for Reasonable and Appropriate Care in the Emergency Department 3 (GRACE-3): Acute Dizziness and Vertigo in the Emergency Department. Academic Emergency Medicine 2023
Primary source for HINTS exam evidence, steroid recommendations, antiviral guidance, and vestibular suppressant duration limits
Level B recommendation for HINTS Plus by trained clinicians
Fishman JM, Burgess C, Waddell A. Corticosteroids for the Treatment of Idiopathic Acute Vestibular Dysfunction (Vestibular Neuritis). Cochrane Database of Systematic Reviews 2011
Modest short-term benefit of corticosteroids; evidence extrapolated to labyrinthitis
Gottlieb M, Peksa GD, Carlson JN. Head Impulse, Nystagmus, and Test of Skew Examination for Diagnosing Central Causes of Acute Vestibular Syndrome. Cochrane Database of Systematic Reviews 2023
Diagnostic accuracy of HINTS: sensitivity 93%, specificity 83%
Wang LL et al. ACR Appropriateness Criteria: Dizziness and Ataxia 2023 Update. Journal of the American College of Radiology 2024
MRI DWI appropriate for neurologic dizziness; CT head low-yield for posterior fossa stroke
Shah VP et al. Diagnostic Accuracy of Physical Examination in ED Patients with Acute Vertigo or Dizziness: Systematic Review and Meta-Analysis for GRACE-3. Academic Emergency Medicine 2023
HINTS Plus sensitivity approaches 99%
Gerlier C et al. Differentiating Central From Peripheral Causes of Acute Vertigo in an Emergency Setting with HINTS, STANDING, and ABCD2. Academic Emergency Medicine 2021
Hydén D, Akerlind B, Peebo M. Inner Ear and Facial Nerve Complications of Acute Otitis Media. Acta Oto-Laryngologica 2006
Bacteriology and virology of otogenic labyrinthitis
Beyea JA, Agrawal SK, Parnes LS. Recent Advances in Viral Inner Ear Disorders. Current Opinion in Otolaryngology and Head and Neck Surgery 2012
Viral etiology, HSV and VZV involvement in labyrinthitis
Zhao Z et al. Cellular Processes Induced by HSV-1 Infections in Vestibular Neuritis. Viruses 2023
Mechanism of HSV-1 in vestibular ganglion damage
Baloh RW. Vestibular Neuritis. New England Journal of Medicine 2003
Classic reference for AVS, vestibular neuritis and labyrinthitis pathophysiology
Aykul Yagcioglu A, Ertugrul G. Sudden Unilateral Hearing Loss and Acute Vestibular Syndrome. Journal of the American Academy of Audiology 2025
Case illustrating pediatric labyrinthitis presentation and audiometric findings
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.